Peter H. Gilligan
- Epidemiology top 0.5%
- Infectious Diseases top 0.2%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Clinical Biochemistry top 0.2%
- Co-authors
- Richard S. SchwalbeJack T. StapletonLawrence J. BrandtLynne V. McFarlandAshwin N. AnanthakrishnanChristina M. SurawiczDavid G. BinionBrian S. Zuckerbraun
- Topics
- Cystic Fibrosis Research Advances (35 papers)Bacterial Identification and Susceptibility Testing (20 papers)Mycobacterium research and diagnosis (19 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologyApplied and Environmental Microbiology
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Peter H. Gilligan
126 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Epidemiology 4.0k
- Infectious Diseases 3.5k
- Pulmonary and Respiratory Medicine 2.2k
- Molecular Biology 1.6k
- Clinical Biochemistry 1.0k
Countries citing papers authored by Peter H. Gilligan
This map shows the geographic impact of Peter H. Gilligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter H. Gilligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter H. Gilligan more than expected).
Fields of papers citing papers by Peter H. Gilligan
This network shows the impact of papers produced by Peter H. Gilligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter H. Gilligan. The network helps show where Peter H. Gilligan may publish in the future.
Co-authorship network of co-authors of Peter H. Gilligan
This figure shows the co-authorship network connecting the top 25 collaborators of Peter H. Gilligan. A scholar is included among the top collaborators of Peter H. Gilligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter H. Gilligan. Peter H. Gilligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 30 | |
| 3 | 1 | |
| 4 | 61 | |
| 5 | 23 | |
| 6 | 11 | |
| 7 | 11 | |
| 8 | 70 | |
| 9 | 291 | |
| 10 | 18 | |
| 11 | 1 | |
| 12 | 153 | |
| 13 | 30 | |
| 14 | 177 | |
| 15 | 193 | |
| 16 | 106 | |
| 17 | 20 | |
| 18 | 125 | |
| 19 | 13 | |
| 20 | 7 |
About Peter H. Gilligan
Peter H. Gilligan is a scholar working on Microbiology, Endocrinology and Clinical Biochemistry, having authored 132 papers that have together received 8.5k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (35 papers), Bacterial Identification and Susceptibility Testing (20 papers) and Mycobacterium research and diagnosis (19 papers). The work is most often cited by research in Infectious Diseases (3.5k citations), Clinical Biochemistry (1.0k citations) and Molecular Medicine (745 citations). Peter H. Gilligan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Richard S. Schwalbe, Jack T. Stapleton, Lawrence J. Brandt, Lynne V. McFarland, Ashwin N. Ananthakrishnan, Christina M. Surawicz, David G. Binion, Brian S. Zuckerbraun, Mark Mellow and Scott Curry. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Applied and Environmental Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.